Sp1 and related factors fail to interact with the NF-κB-proximal G/C box in the LTR of a replication competent, brain-derived strain of HIV-1 (YU-2)

Journal of NeuroVirology

Volumn 4, Issue 3, 1998, Pages 312-323

  Millhouse, Scott ^a   Krebs, Fred C ^a   Yao, Jing ^a   McAllister, John J ^a   Conner, Jean ^a   Ross, Heather ^a   Wigdahl, Brian ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Astrocyte; CNS; HIV 1; LTR; Lymphocyte; Monocyte; Sp1; Sp3

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; TRANSCRIPTION FACTOR SP1; VIRUS DNA;

ARTICLE; ASTROCYTE; BINDING AFFINITY; BINDING SITE; BRAIN INFECTION; CONTROLLED STUDY; DNA SEQUENCE; DNA TRANSFECTION; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; LYMPHOCYTE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; STRUCTURE ACTIVITY RELATION; VIRUS GENE; VIRUS REPLICATION;

EID: 0031810313     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289809114532     Document Type: Article

References (42)

1. Ait-Khaled M, McLaughlin JE, Johnson MA, Emery VC (1995). Distinct HIV-1 long terminal repeat quasispecies present in nervous tissues compared to that in lung, blood and lymphoid tissues of an AIDS patient. AIDS 9: 675-683.
2. Apt D, Watts RM, Suske G, Bernard HU (1996). High Sp1/Sp3 ratios in epithelial cells during epithelial differentiation and cellular transformation correlate with the activation of the HPV-16 promoter. Virology 224: 281-291.
3. Bagasra O, Lavi E, Bobroski L, Khalili K, Pestaner JP, Tawadros R, Pomerantz RJ (1996). Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by die combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 10: 573-585.
4. Brack-Werner R, Kleinschmidt A, Ludvigsen A, Mellert W, Neumann M, Herrmann R, Khim MC, Burny A, Muller-Lantzsch N, Stavrou D, Erfle V (1992). Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines. AIDS 6: 273-285.
5. Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
6. Birnbaum MJ, van Wijnen AJ, Odgren PR, Last TJ, Suske G, Stein GS, Stein JL (1995). Sp1 trans-activation of cell cycle regulated promoters is selectively repressed by Sp3. Biochemistry 34: 16503-16508.
7. Cullen BR (1991). Regulation of human immunodeficiency virus replication. Annu Rev Micro 45: 219-250.
8. Desai-Yajnik V, Samuels HH (1993). The NF-kappa B and Sp1 motifs of the human immunodeficiency virus type 1 long terminal repeat function as novel thyroid hormone response elements. MoI Cell Biol 13: 5057-5069.
9. Dewhurst S, Bresser J, Stevenson M, Sakai K, Evinger-Hodges MJ, Volsky DJ (1987). Susceptibility of human glial cells to infection with human immunodeficiency virus (HIV). FEBS Lett 213: 138-143.
10. Dignam JD, Lebovitz RM, Roeder RG (1983). Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11: 1475-1489.
11. Garner MM, Revzin A (1981). A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: application to components of the Escherichia coli lactose operon regulatory system. Nuc Acids Res 9: 3047-3060.
12. Goodenow MM, Huet T, Saurin W, Kwok S, Sninsky J, Wain-Hobson S (1989). HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions. J Acquir Immune Defic Syndr Hum Retrovirol 2: 344-352.
13. Hagen G, Muller S, Beato M, Suske G (1992). Cloning by recognition site screening of two novel GT box binding proteins: a family of Sp1 related genes. Nucleic Acids Res 20: 5519-5525.
14. Harrich D, Garcia J, Wu F, Mitsuyasu R, Gonazalez J, Gaynor R (1989). Role of Sp1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat. J Virol 63: 2585-2591.
15. Jones KA, Kadonaga JT, Luciw PA, Tjian R (1986). Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science 232: 755-759.
16. Jones KA, Peterlin BM (1994). Control of RNA initiation and elongation at the HIV-1 promoter. Annu Rev Biochem 63: 717-743.
17. Katz RA, Skalka AM (1990). Generation of diversity in retroviruses. Annu Rev Genet 24: 409-445.
18. Kennett SB, Udvadia AJ, Horitz JM (1997). Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription. Nucleic Acids Res 25: 3110-3117.
19. Kim SJ, Onwuta US, Lee YI, Li R, Botchman MR, Robbins PD (1992). The retinoblastoma gene product regulates Sp1-mediated transcription. Mol Cell Biol 12: 2455-2463.
20. Kim JY, Gonzalez-Scarano F, Zeichner SL, Alwine JC (1993). Replication of type 1 human immunodeficiency viruses containing linker substitution mutations in the -201 to -130 region of the long terminal repeat. J Virol 67: 1658-1662.
21. Kingman SM, Kingman AJ (1996). The regulation of human immunodeficiency virus type-1 gene expression. Eur J Biochem 240: 491-507.
22. Kingsley C, Winoto A (1992). Cloning of GT box-binding proteins: a novel Sp1 multigene family regulating T-cell receptor gene expression. Mol Cell Biol 12: 4251-4261.
23. Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, Yungbluth M, Janotta F, Aksamit A, Martin MA, Fauci AS (1986). Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233: 1089-1093.
24. Koken SE, van Wamel JL, Goudsmit J, Berkhout B, Geelen JL (1992). Natural variants of the HIV-1 long terminal repeat: analysis of promoters with duplicated DNA regulatory motifs. Virology 191: 968-972.
25. Kriwacki RW, Schultz SC, Steitz TA, Caradonna JP (1992). Sequence-specific recognition of DNA by zinc-finger peptides derived from the transcription factor Sp1. Proc Natl Acad Sci USA 89: 9759-9763.
26. Li Y, Kappes JC, Conway JA, Price RW, Shaw GM, Hahn BH (1991). Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes. J Virol 65: 3973-3985.
27. Li Y, Mak G, Franza BR Jr (1994). In vitro study of functional involvement of Sp1, NF-kappa B/Rel, and API in phorbol 12-myristate 13-acetate-mediated HIV-1 long terminal repeat activation. J Biol Chem 269: 30616-30619.
28. Majello B, De Luca P, Hagen G, Suske G, Lania L (1994). Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1. Nucleic Acids Res 22: 4914-4921.
29. Michael NL, D'Arcy L, Ehrenberg PK, Redfield RR (1994). Naturally occurring genotypes of the human immunodeficiency virus type 1 long terminal repeat display a wide range of basal and tat-induced transcriptional activities. J Virol 68: 3163-3174.
30. Moses AV, Ibanez C, Gaynor R, Ghazal P, Nelson JA (1994). Differential role of long terminal repeat control elements for the regulation of basal and Tat-mediated transcription of the human immunodeficiency virus in stimulated and unstimulated primary human macrophages. J Virol 68: 298-307.
31. Myers G, Foley B, Mellors JW, Korber B, Wain-Hobson S, Jeang K-T, (eds) (1996). Human retroviruses and AIDS 1996. A compilation and analysis of nucleic and amino acid sequences. Los Alamos National Laboratory, Los Alamos, NM.
32. Nuovo GJ, Gallery F, MacConnell P, Braun A (1994). In situ detection of PCR-amplified HIV-1 nucleic acids and tumor necrosis factor alpha RNA in the central nervous system. Am J Pathol 144: 659-666.
33. Perkins ND, Edwards NL, Duckett CS, Agranoff AB, Schmid RM, Nabel GJ (1993). A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation. EMBO J 12: 3551-3558.
34. Price RW (1994). Understanding the AIDS Dementia Complex (ADC): The challenge of HIV and its effects on the central nervous system. In: HIV, AIDS and the Brain. Price RW, Perry SW III, (eds). Raven Press: New York, pp 1-45.
35. Ross EK, Buckler-White AJ, Rabson AB, Englund G, Martin MA (1991). Contribution of NF-kappa B and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types. J Virol 65: 4350-4358.
36. Sune C, Garcia-Blanco MA (1995). Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat. J Virol 69: 6572-6576.
37. Tornatore C, Nath A, Amemiya K, Major EO (1991). Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta. J Virol 65: 6094-6100.
38. Tornatore C, Chandra R, Berger JR, Major EO (1994). HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 44: 481-487.
39. Wen SC, Ku DH, De Luca A, Claudio PP, Giordano A, Calabretta B (1995). ets-2 regulates cdc2 kinase activity in mammalian cells: coordinated expression of cdc2 and cyclin A. Exp Cell Res 217: 8-14.
40. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MBA (1986). Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 83: 7089-7093.
41. Wingender E, Kel AE, Kel OV, Karas H, Heinemeyer T, Dietze P, Knuppel R, Romaschenko AG, Kolchanov NA (1997). TRANSFAC, TRRD and COMPEL: towards a federated database system on transcriptional regulation. Nucleic Acids Res 25: 265-268.
42. Zeichner SL, Kim JY, Alwine JC (1991). Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus type 1 long terminal repeat. J Virol 65: 2436-2444.